Mystical Encounters, With and Without Drugs
Whatever the brain does on drugs, it may be capable of without them.
Other Science - Page 3
Can Psilocybin Assisted Psychotherapy Change Attachment Style?
Shifting from insecure to secure attachments may help rescue patients from pathological mental states.
Finding the Psychedelic Sweet Spot
The relationship between efficacy and potency is a key concept in understanding psychedelic drug pharmacology.
The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy
Recent antidepressant exposure may reduce the treatment efficacy of MDMA.
Ayahuasca’s Role in the Entourage Effect and Depression
Research suggests that DMT may not be the only compound responsible for ayahuasca's effects.
Researchers Synthesize Novel Compound, Tabernanthalog, a Non-Hallucinogenic Ibogaine Analog
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
Hamilton Morris Synthesizes 5-MeO-DMT in “Pharmacopeia”
“I believe one person can produce enough 5-MeO-DMT to supply everyone that would ever want it.”
Connectome-Specific Harmonic Waves: A Deeper Dive Into Integrated Information Theory (IIT)
According to IIT, psychedelics cause concepts to form more links with each other than usual. This might explain several phenomena observed in psychedelic mind-states.
Ketamine Helps People Dislike Themselves Less
New research shows that ketamine reduces self-dislike, loosening the rigid prejudice toward oneself that can constitute depression.
Quipazine: A Long-Standing Enigma in Psychedelic Research
The “psychedelic drug” label appears to define a clear-cut category. However, there are lesser-known research chemicals that depict more diffuse boundaries in this classification.